These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26867730)

  • 1. MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn's disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis.
    Bhatnagar G; Makanyanga J; Ganeshan B; Groves A; Rodriguez-Justo M; Halligan S; Taylor SA
    Abdom Radiol (NY); 2016 Jul; 41(7):1261-9. PubMed ID: 26867730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI texture analysis (MRTA) of T2-weighted images in Crohn's disease may provide information on histological and MRI disease activity in patients undergoing ileal resection.
    Makanyanga J; Ganeshan B; Rodriguez-Justo M; Bhatnagar G; Groves A; Halligan S; Miles K; Taylor SA
    Eur Radiol; 2017 Feb; 27(2):589-597. PubMed ID: 27048528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
    Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
    Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.
    Taylor SA; Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Forbes A; Cohen R; Windsor A; Obichere A; Hansmann A; Rajan J; Novelli M; Halligan S
    Radiology; 2009 May; 251(2):369-79. PubMed ID: 19276323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Surveillance MR Enterography (MRE) in Asymptomatic Children and Adolescents With Crohn's Disease.
    Chu KF; Moran CJ; Wu K; Kaplan JL; Savarino JR; Board T; Israel EJ; Winter HS; Gee MS
    J Magn Reson Imaging; 2019 Dec; 50(6):1955-1963. PubMed ID: 31145502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography.
    Quaia E; Cabibbo B; Sozzi M; Gennari AG; Pontello M; Degrassi F; Cova MA
    Acad Radiol; 2014 Oct; 21(10):1225-32. PubMed ID: 24998692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving role of MRI in Crohn's disease.
    Yacoub JH; Obara P; Oto A
    J Magn Reson Imaging; 2013 Jun; 37(6):1277-89. PubMed ID: 23712842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Texture Analysis on Gadoxetic Acid-enhanced MR for Detecting Liver Fibrosis in a Rat Model.
    Xu J; Wang X; Jin ZY; You Y; Wang Q; Wang ST; Xue HD
    Chin Med Sci J; 2019 Mar; 34(1):24-32. PubMed ID: 30961777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Crohn's disease with diffusion images versus contrast-enhanced images in pediatric using MR enterography with histopathological correlation.
    Masselli G; De Vincentiis C; Aloi M; Guida M; Cao R; Cartocci G; Miele V; Grassi R
    Radiol Med; 2019 Dec; 124(12):1306-1314. PubMed ID: 31317380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index.
    Steward MJ; Punwani S; Proctor I; Adjei-Gyamfi Y; Chatterjee F; Bloom S; Novelli M; Halligan S; Rodriguez-Justo M; Taylor SA
    Eur J Radiol; 2012 Sep; 81(9):2080-8. PubMed ID: 21924572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
    Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
    J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced MR enterography as a stand-alone tool to evaluate Crohn's disease in a paediatric population.
    Spieler B; Hindman N; Levy J; Zabrieski K; Sahlein D; Seuss C; Kim S
    Clin Radiol; 2013 Oct; 68(10):1024-30. PubMed ID: 23796211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Texture Analysis of Magnetic Resonance Enterography Contrast Enhancement Can Detect Fibrosis in Crohn Disease Strictures.
    Tabari A; Kilcoyne A; Jeck WR; Mino-Kenudson M; Gee MS
    J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):533-538. PubMed ID: 31365485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning.
    Low RN; Francis IR; Politoske D; Bennett M
    J Magn Reson Imaging; 2000 Feb; 11(2):127-35. PubMed ID: 10713944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens.
    Tielbeek JA; Ziech ML; Li Z; Lavini C; Bipat S; Bemelman WA; Roelofs JJ; Ponsioen CY; Vos FM; Stoker J
    Eur Radiol; 2014 Mar; 24(3):619-29. PubMed ID: 24037299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn's disease.
    Bernstein CN; Greenberg H; Boult I; Chubey S; Leblanc C; Ryner L
    Am J Gastroenterol; 2005 Nov; 100(11):2493-502. PubMed ID: 16279905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in dynamic contrast-enhanced pharmacokinetic and diffusion-weighted imaging parameters reflect response to anti-TNF therapy in Crohn's disease.
    Bhatnagar G; Dikaios N; Prezzi D; Vega R; Halligan S; Taylor SA
    Br J Radiol; 2015; 88(1055):20150547. PubMed ID: 26402217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of dynamic contrast enhancement of the small bowel in active Crohn's disease using 3D MR enterography.
    Knuesel PR; Kubik RA; Crook DW; Eigenmann F; Froehlich JM
    Eur J Radiol; 2010 Mar; 73(3):607-13. PubMed ID: 19131201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the arterial input function from dynamic contrast-enhanced MRI data with compensation for flow enhancement (II): Applications in spine diagnostics and assessment of crohn's disease.
    van Schie JJN; Lavini C; van Vliet LJ; Kramer G; Pieters-van den Bos I; Marcus JT; Stoker J; Vos FM
    J Magn Reson Imaging; 2018 May; 47(5):1197-1204. PubMed ID: 29193469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?
    Quaia E; Sozzi M; Gennari AG; Pontello M; Angileri R; Cova MA
    J Magn Reson Imaging; 2016 Mar; 43(3):688-97. PubMed ID: 26250897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.